Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by floatinketuckyon Mar 22, 2022 9:33am
165 Views
Post# 34533954

$TLTFF The Gold Standard for NMIBC NON-RESPONSE!!

$TLTFF The Gold Standard for NMIBC NON-RESPONSE!!NMIBC space is piviting to the pivital phase 2 for a reason.

BTD AND AA INPROGRESS AS PER THE FDA.

WHAT OTHER NMIBC COMPETITORS CAN SAY THAT?

Comp for NMIBC are being affected by the TLT DATA. 

TLTFF long

The science and data are very very very good.

Almost done with Q1 2022. 
Latest data reported nov 29 2021.

Do ya'll think the FDA will be looking at the current data to date?  mmmmm  Let's go with YES FOR SURE.

They brought the piv ph2 study up very carefully. 
They are doing very good work.

Old school price and volume are supporting a near term blue sky breakout..

JMO...

Why do you think that 3 month chart looks the way it does?



<< Previous
Bullboard Posts
Next >>